Skip to main content

Sanofi

corporate_fare Company Profile

Sanofi

SNY·NASDAQ·Life Sciences·CIK 0001121404

Sanofi is a biopharmaceutical company focused on improving people's lives through its R&D-driven and AI-powered approach. The company's activities are organized within the Biopharma operating segment, which includes categories such as Immunology, Rare Diseases, Neurology, Oncology, Other Medicines, and Vaccines. Sanofi operates in a global market characterized by a growing and aging population with high unmet medical needs. The company emphasizes innovation in R&D and advanced manufacturing to launch new medicines and vaccines. It also leverages digital technologies and advanced data analytics across sales, marketing, R&D, and manufacturing. The pharmaceutical industry faces challenges including geopolitical uncertainties, inflation, supply shortages, and government budget tightening, which put pressure on healthcare costs. Payers are scrutinizing prices and reimbursement criteria, demanding real-life outcome demonstrations for efficacy. Sanofi aims to contribute to improved patient access and the development of innovative, cost-effective medicines.

Sanofi (NASDAQ:SNY) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 48 items for SNY at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-19, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 8/10, with 16 rated 8 or above. Recent SEC coverage for SNY spans 6-K.

Recent high-impact activity:

  • Sanofi Wins FDA Nod for First Oral Gaucher Therapy, EU Approval for New Rabies Shot
  • Sanofi Beats Q3, Lifts 2026 Outlook as Dupixent Tops €5.7B
  • Sanofi Pays Up to $8B to Expand Regeneron Alliance With Four Long-Acting Drugs
  • Sanofi Divests 20 Mature Medicines and 3 Plants to Cheplapharm for 26.4% Equity Stake
  • Sanofi's MenQuadfi Wins EU Nod for Infants, Broadening Its Meningococcal Vaccine Reach

Financial Snapshot

Fiscal year ended December 31, 2025
Net Income
$7.85B
Diluted EPS
$6.37
Op. Cash Flow
$10.75B
Free Cash Flow
$7.21B
Gross Profit
$33.67B
Operating Income
$6.34B
Cash & Equivalents
$877M
Total Debt
$14.25B
Debt / Equity
0.20×
Shares Outstanding
1.22B sh
Source: 20-F · filed 2026-02-17 · accession 0001628280-26-008403

Short Interest & Short Volume

2.85 days to cover

FINRA reported short interest of 12,291,525 shares in SNY as of the October 30, 2026 settlement, a 5.9% increase from the prior period — about 2.9 days to cover at its recent average daily volume. On November 20, 2026, 20.5% of SNY volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)12,291,525 shares as of October 30, 2026
Change vs prior period▲ 5.9%
Days to cover2.85 at avg daily volume of 4,314,663
Daily short volume (FINRA facilities)20.5% of 1,412,695 shares on November 20, 2026
5-day average short volume25.8%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Insider Transactions

SNY files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.

Browse all tickers starting with S →
$46.52
52-week range · as of 2026-09-17 $40.89 – $52.68
Market cap
$111.69B
Volume
4.3M (1.0× avg)
3-mo avg 4.3M
Live data · 2026-11-21 12:20 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed SNY - Latest Insights

SNY
Nov 19, 2026, 8:59 AM EST
Source: Benzinga
Importance Score:
7
Price at Filing: $46.16
Real-time Price: $46.52 info
Change: +$0.365 (+0.79%) info
Market Cap: $111.686B info
SNY
Oct 30, 2026, 3:54 AM EDT
Source: Seeking Alpha
Importance Score:
8
Price at Filing: $43.03
Real-time Price: $46.52 info
Change: +$3.49 (+8%) info
Market Cap: $111.686B info
SNY
Oct 01, 2026, 5:22 AM EDT
Source: Seeking Alpha
Importance Score:
8
Price at Filing: $41.31
Real-time Price: $46.52 info
Change: +$5.21 (+13%) info
Market Cap: $111.686B info
SNY
Sep 17, 2026, 6:09 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $42.71
Real-time Price: $46.52 info
Change: +$3.81 (+9%) info
Market Cap: $111.686B info
SNY
Aug 06, 2026, 6:02 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $43.26
Real-time Price: $46.52 info
Change: +$3.26 (+8%) info
Market Cap: $111.686B info
SNY
Jul 30, 2026, 7:34 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $43.66
Real-time Price: $46.52 info
Change: +$2.86 (+7%) info
Market Cap: $111.686B info
SNY
Jul 30, 2026, 6:28 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $43.47
Real-time Price: $46.52 info
Change: +$3.05 (+7%) info
Market Cap: $111.686B info
SNY
Jul 27, 2026, 6:10 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $43.90
Real-time Price: $46.52 info
Change: +$2.62 (+6%) info
Market Cap: $111.686B info
SNY
Jul 10, 2026, 8:35 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $43.69
Real-time Price: $46.52 info
Change: +$2.83 (+6%) info
Market Cap: $111.686B info
SNY
Jul 07, 2026, 9:02 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $43.16
Real-time Price: $46.52 info
Change: +$3.36 (+8%) info
Market Cap: $111.686B info
SNY
Jun 30, 2026, 1:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $43.43
Real-time Price: $46.52 info
Change: +$3.09 (+7%) info
Market Cap: $111.686B info
SNY
Jun 24, 2026, 8:43 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $41.77
Real-time Price: $46.52 info
Change: +$4.75 (+11%) info
Market Cap: $111.686B info
SNY
Jun 23, 2026, 1:15 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $41.66
Real-time Price: $46.52 info
Change: +$4.86 (+12%) info
Market Cap: $111.686B info
SNY
Jun 23, 2026, 1:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $41.66
Real-time Price: $46.52 info
Change: +$4.86 (+12%) info
Market Cap: $111.686B info
SNY
Jun 22, 2026, 8:43 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $41.10
Real-time Price: $46.52 info
Change: +$5.42 (+13%) info
Market Cap: $111.686B info
SNY
Jun 19, 2026, 6:31 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $42.20
Real-time Price: $46.52 info
Change: +$4.32 (+10%) info
Market Cap: $111.686B info
SNY
Jun 12, 2026, 6:09 PM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $44.25
Real-time Price: $46.52 info
Change: +$2.27 (+5%) info
Market Cap: $111.686B info
SNY
Jun 12, 2026, 11:41 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $44.35
Real-time Price: $46.52 info
Change: +$2.17 (+5%) info
Market Cap: $111.686B info
SNY
Jun 08, 2026, 1:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $45.02
Real-time Price: $46.52 info
Change: +$1.50 (+3%) info
Market Cap: $111.686B info
SNY
May 28, 2026, 1:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $44.75
Real-time Price: $46.52 info
Change: +$1.77 (+4%) info
Market Cap: $111.686B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets